| + |
sonidegib | down-regulates
chemical inhibition
|
SMO |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-169203 |
|
|
Homo sapiens |
Leukemia Cell |
| pmid |
sentence |
| 21041712 |
Cyclopamine with improved solubility (ipi-926), smo inhibitors that considerably differ in structure from cyclopamine (gdc-0499, lde225, bms-833923, xl-139, pf-0449913), inhibitors of the transformation of inactive smo into active smo (sant 74-75), and inhibitors of the transport of cytoplasmic inactive smo to cilia (sant 1-4) have been developed to date. |
|
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-193630 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| Other |
|
|
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-174593 |
|
|
Homo sapiens |
Glioblastoma Cell |
| pmid |
sentence |
| 21679342 |
Cyclopamine with improved solubility (ipi-926), smo inhibitors that considerably differ in structure from cyclopamine (gdc-0499, lde225, bms-833923, xl-139, pf-0449913), inhibitors of the transformation of inactive smo into active smo (sant 74-75), and inhibitors of the transport of cytoplasmic inactive smo to cilia (sant 1-4) have been developed to date. |
|
| Publications: |
3 |
Organism: |
Homo Sapiens |